Nine weeks versus 1 year adjuvant trastuzumab in combination with

Nine weeks versus 1 year adjuvant trastuzumab in combination with trastuzumab In 2006, trastuzumab plus chemotherapy was approved to treat patients after their HER2-overexpressing breast tumors were surgically removed trastuzumab Trastuzumab side effects · heart problems; · nausea, diarrhea, weight loss; · headache; · trouble sleeping, feeling tired; · low blood cell

trastuzumab ของยาตัวใหม่ที่กระตุ้นให้เกิดการแพ้ยาในขณะที่ยาต้นแบบไ ม่มี เป็นต้น Trastuzumab เป็น humanized monoclonal antibody ที่ออกฤทธิ์ต้าน HER2 ซึ่งเป็น growth factor receptor

trastuzumab Trastuzumab deruxtecan may cause hair loss Any hair loss caused should be temporary and in most cases your hair will begin to grow back once your treatment has Interpretation We have shown that 6-month trastuzumab treatment is non-inferior to 12-month treatment in patients with HER2-positive early